Guided Therapeutics (GTHP) Financial Statements

Guided Therapeutics's market cap is currently $20.90M. The company's EPS TTM is $-0.045; its P/E ratio is -8.16; Guided Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.